The biosynthesis and biological activity of colloidal AgO nanocrystals have not been well studied, although they have potential applications in many fields. For the first time, we developed a reducing agent free, cost-effective technique for AgO biosynthesis using Xanthomonas sp. P5. The optimal conditions for AgO synthesis were 50 °C, pH 8, and 2.5 mM AgNO. Using these conditions the yield of AgO obtained at 10 h was about five times higher than that obtained at 12 h under unoptimized conditions. AgO was characterized by FESEM-EDS, TEM, dynamic light scattering, XRD, and UV-Visible spectroscopy. Indoleacetic acid produced by the strain P2 was involved in the synthesis of AgO. AgO exhibited a broad antimicrobial spectrum against several human pathogens. Furthermore, AgO exhibited 1,1-diphenyl-2-picrylhydrazyl (IC = 25.1 µg/ml) and 2,2'-azinobis-3-ethylbenzothiazoline-6-sulfonate (IC = 16.8 µg/ml) radical scavenging activities, and inhibited collagenase (IC = 27.9 mg/ml). Cytotoxicity of AgO was tested in fibroblast cells and found to be non-toxic, demonstrating biocompatibility.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00449-018-2044-7 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!